Skip to content

Results for “Relizorb”

Registry
Country / market
Risk class
More classes (11)
Verified

Category (EMDN)

Browse by category

11 devices foundsorted by relevance

Clear all

  • RELiZORB 200209 / 200211

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    None Registry: GUDID Class:II

  • Relizorb 100103

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    Withdrawn Registry: GUDID Class:II

  • RELiZORB 100300/100301

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    None Registry: GUDID Class:II

  • Relizorb

    Alcresta, Inc.,FDA registration: United States
    Active Regimes: De Novo Registry: De Novo Class:II

  • RELiZORB (100300/ 100301)

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    Active Regimes: 510(k) Registry: 510(k) Class:II

  • RELiZORB

    Alcresta Therapeutics, Inc.,United States(FDA applicant) Group of variants
    Active Regimes: 510(k) Registry: 510(k) Class:II

  • RELiZORB®

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    Active Regimes: 510(k) Registry: 510(k) Class:II

  • RELiZORB (100300/100301)

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    Active Regimes: 510(k) Registry: 510(k) Class:II

  • Enzyme Packed Cartridge - RELiZORB

    Alcresta Therapeutics, Inc.,United States(FDA applicant)
    Active Regimes: 510(k) Registry: 510(k) Class:II

Showing 1-11 of 11